Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1271
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

SYMPOSIUM

Non-FDG PET in the practice of oncology

Caroli P, Nanni C, Rubello D, Alavi A, Fanti S

Year : 2010| Volume: 47| Issue : 2 | Page no: 120-125

   This article has been cited by
 
1 Rare encounters: Primary pineal malignant melanoma with lepto-meningeal spread. Case report and literature review on management challenges and outcomes
Farouk Hajhouji,Mario Ganau,Cebula Helene,Antonio Romano,Arthur Gubian,Francois Proust,Salvatore Chibbaro
Journal of Clinical Neuroscience. 2019; 65: 161
[Pubmed]  [Google Scholar] [DOI]
2 The role of new PET tracers for lung cancer
Sachin V. Kamat,Teresa A. Szyszko,Manil Subesinghe,Barbara M. Fischer,Sugama Chicklore,Victoria Warbey,Gary J. Cook
Minerva Pneumologica. 2019; 58(1)
[Pubmed]  [Google Scholar] [DOI]
3 Direct Incorporation of [11C]CO2 into Asymmetric [11C]Carbonates
Abdul Karim Haji Dheere,Salvatore Bongarzone,Dinah Shakir,Antony Gee
Journal of Chemistry. 2018; 2018: 1
[Pubmed]  [Google Scholar] [DOI]
4 A chiral template-driven synthesis of a 3'-deoxy-3'-18F-fluorothymidine precursor
Papiya Dey,K.S. Ajish Kumar,Anubha Sharma,Subrata Chattopadhyay
European Journal of Medicinal Chemistry. 2018; 143: 1457
[Pubmed]  [Google Scholar] [DOI]
5 Radionecrosis versus disease progression in brain metastasis. Value of 18 F-DOPA PET/CT/MR
J. Hernández Pinzón,D. Mena,M. Aguilar,F. Biafore,G. Recondo,M. Bastianello
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 2016; 35(5): 332
[Pubmed]  [Google Scholar] [DOI]
6 18F-FDG, as a single imaging agent in assessing cancer, shows the ongoing biological phenomena in many domains
Thomas C. Kwee,Saeid Gholami,Thomas J. Werner,Domenico Rubello,Abass Alavi,Poul F. Høilund-Carlsen
Nuclear Medicine Communications. 2016; 37(4): 333
[Pubmed]  [Google Scholar] [DOI]
7 Radionecrosis versus progresión de la enfermedad en metástasis cerebrales: valor del 18F-DOPA PET/TC/RM
J. Hernández Pinzón,D. Mena,M. Aguilar,F. Biafore,G. Recondo,M. Bastianello
Revista Española de Medicina Nuclear e Imagen Molecular. 2016; 35(5): 332
[Pubmed]  [Google Scholar] [DOI]
8 FDG PET/CT in cancer: comparison of actual use with literature-based recommendations
Henrik Petersen,Paw Christian Holdgaard,Poul Henning Madsen,Lene Meldgaard Knudsen,Dorte Gad,Anders Eggert Gravergaard,Max Rohde,Christian Godballe,Bodil Elisabeth Engelmann,Karsten Bech,Dorte Teilmann-Jørgensen,Ole Mogensen,Jens Karstoft,Jørgen Johansen,Janne Buck Christensen,Allan Johansen,Poul Flemming Høilund-Carlsen
European Journal of Nuclear Medicine and Molecular Imaging. 2016; 43(4): 695
[Pubmed]  [Google Scholar] [DOI]
9 64Cu2+ Ions as PET Probe: An Emerging Paradigm in Molecular Imaging of Cancer
Rubel Chakravarty,Sudipta Chakraborty,Ashutosh Dash
Molecular Pharmaceutics. 2016; 13(11): 3601
[Pubmed]  [Google Scholar] [DOI]
10 Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors
Martina Benešová,Ulrike Bauder-Wüst,Martin Schäfer,Karel D. Klika,Walter Mier,Uwe Haberkorn,Klaus Kopka,Matthias Eder
Journal of Medicinal Chemistry. 2016; 59(5): 1761
[Pubmed]  [Google Scholar] [DOI]
11 The role of new PET tracers for lung cancer
Teresa A. Szyszko,Connie Yip,Peter Szlosarek,Vicky Goh,Gary J.R. Cook
Lung Cancer. 2016; 94: 7
[Pubmed]  [Google Scholar] [DOI]
12 Radiofármacos utilizados en la tomografía por emisión de positrones: presente y perspectivas de futuro
C. Olivas Arroyo
Radiología. 2016; 58(6): 468
[Pubmed]  [Google Scholar] [DOI]
13 The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases
Simone Chevalier,Serge Moffett,Eric Turcotte,Murillo Luz,Lyne Chauvette,Vilma Derbekyan,Eleonora Scarlata,Fatima Zouanat,Armen G. Aprikian,Maurice Anidjar
EJNMMI Research. 2015; 5(1)
[Pubmed]  [Google Scholar] [DOI]
14 Performance of FLT-PET for pulmonary lesion diagnosis compared with traditional FDG-PET: A meta-analysis
Zixing Wang,Yuyan Wang,Xin Sui,Wei Zhang,Ruihong Shi,Yingqiang Zhang,Yonghong Dang,Zhen Qiao,Biao Zhang,Wei Song,Jingmei Jiang
European Journal of Radiology. 2015;
[Pubmed]  [Google Scholar] [DOI]
15 Nuclear medicine imaging of endocrine neoplasms
Ka Kit Wong,Asha Kandathil,Maria Cristina Marzola,Milton D. Gross,Domenico Rubello
Nuclear Medicine Communications. 2014; 35(1): 1
[Pubmed]  [Google Scholar] [DOI]
16 18F-DOPA PET/Computed Tomography Imaging
Sotirios Chondrogiannis,Maria Cristina Marzola,Domenico Rubello
PET Clinics. 2014;
[Pubmed]  [Google Scholar] [DOI]
17 11C-choline PET/CT tumor recurrence detection and survival prediction in post-treatment patients with high-grade gliomas
Wanhu Li,Li Ma,Xiaoyue Wang,Jujie Sun,Suzhen Wang,Xudong Hu
Tumor Biology. 2014;
[Pubmed]  [Google Scholar] [DOI]
18 Molecular Imaging of Pulmonary Nodules
Anna Margherita Maffione,Gaia Grassetto,Lucia Rampin,Sotirios Chondrogiannis,Maria Cristina Marzola,Valentina Ambrosini,Domenico Rubello
American Journal of Roentgenology. 2014; 202(3): W217
[Pubmed]  [Google Scholar] [DOI]
19 Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy
Marco Ravanelli,Davide Farina,Mauro Morassi,Elisa Roca,Giuseppe Cavalleri,Gianfranco Tassi,Roberto Maroldi
European Radiology. 2013; 23(12): 3450
[Pubmed]  [Google Scholar] [DOI]
20 Normal biodistribution pattern and physiologic variants of 18F-DOPA PET imaging
Sotirios Chondrogiannis,Maria Cristina Marzola,Adil Al-Nahhas,Thirumalesha D. Venkatanarayana,Alberto Mazza,Giuseppe Opocher,Domenico Rubello
Nuclear Medicine Communications. 2013; : 1
[Pubmed]  [Google Scholar] [DOI]
21 Mammary cancer bone metastasis follow-up using multimodal small-animal MR and PET imaging
Doré-Savard, L. and Barrière, D.A. and Midavaine, É. and Bélanger, D. and Beaudet, N. and Tremblay, L. and Beaudoin, J.-F. and Turcotte, E.E. and Lecomte, R. and Lepage, M. and Sarret, P.
Journal of Nuclear Medicine. 2013; 54(6): 944-952
[Pubmed]  [Google Scholar]
22 PET and MR imaging: The odd couple or a match made in heaven?
Catana, C. and Guimaraes, A.R. and Rosen, B.R.
Journal of Nuclear Medicine. 2013; 54(5): 815-824
[Pubmed]  [Google Scholar]
23 Oncological applications of positron emission tomography for evaluation of the thorax
Kwee, T.C. and Torigian, D.A. and Alavi, A.
Journal of Thoracic Imaging. 2013; 28(1): 11-24
[Pubmed]  [Google Scholar]
24 Oncological Applications of Positron Emission Tomography for Evaluation of the Thorax
Thomas C. Kwee,Drew A. Torigian,Abass Alavi
Journal of Thoracic Imaging. 2013; 28(1): 11
[Pubmed]  [Google Scholar] [DOI]
25 Application of11C-acetate positron-emission tomography (PET) imaging in prostate cancer: systematic review and meta-analysis of the literature
Beheshti Mohsen,Treglia Giorgio,Zakavi Seyed Rasoul,Langsteger Werner,Ghodsi Rad Mohammad Ali,Dabbagh Kakhki Vahid Reza,Sadeghi Ramin
BJU International. 2013; 112(8): 1062
[Pubmed]  [Google Scholar] [DOI]
26 Easy upgrade of the TRACERLab FX C Pro for [11C]carboxylation reactions: Application to the routine production of [1-11C]acetate
Stéphane Le Helleix,Frédéric Dollé,Bertrand Kuhnast
Applied Radiation and Isotopes. 2013; 82: 7
[Pubmed]  [Google Scholar] [DOI]
27 18F-DOPA PET/CT biodistribution consideration in 107 consecutive patients with neuroendocrine tumours
Sotirios Chondrogiannis,Gaia Grassetto,Maria Cristina Marzola,Lucia Rampin,Arianna Massaro,Elena Bellan,Alice Ferretti,Alberto Mazza,Adil Al-Nahhas,Domenico Rubello
Nuclear Medicine Communications. 2012; 33(2): 179
[Pubmed]  [Google Scholar] [DOI]
28 Positron Emission Tomography Imaging of Meningioma in Clinical Practice
Jan Frederick Cornelius,Karl Josef Langen,Gabriele Stoffels,Daniel Hänggi,Michael Sabel,Hans Jakob Steiger
Neurosurgery. 2012; 70(4): 1033
[Pubmed]  [Google Scholar] [DOI]
29 Description of high purity and high specific activity of [11C]Choline synthesis using TRACERlab FXc module, and detailed report of quality controls
Biasiotto, G. and Bertagna, F. and Biasiotto, U. and Rodella, C. and Bosio, G. and Caimi, L. and Bettinsoli, G. and Giubbini, R.
Medicinal Chemistry. 2012; 8(6): 1182-1189
[Pubmed]  [Google Scholar]
30 SPECT and PET imaging of meningiomas
Valotassiou, V. and Leondi, A. and Angelidis, G. and Psimadas, D. and Georgoulias, P.
The Scientific World Journal. 2012; 2012(412580)
[Pubmed]  [Google Scholar]
31 Positron emission tomography imaging of meningioma in clinical practice: Review of literature and future directions
Cornelius, J.F. and Josef Langen, K. and Stoffels, G. and Hänggi, D. and Sabel, M. and Jakob Steiger, H.
Neurosurgery. 2012; 70(4): 1033-1041
[Pubmed]  [Google Scholar]
32 New PET radiopharmaceuticals beyond FDG for brain tumor imaging
Gulyás, B. and Halldin, C.
Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2012; 56(2): 173-190
[Pubmed]  [Google Scholar]
33 18F-DOPA PET/CT biodistribution consideration in 107 consecutive patients with neuroendocrine tumours
Chondrogiannis, S. and Grassetto, G. and Marzola, M.C. and Rampin, L. and Massaro, A. and Bellan, E. and Ferretti, A. and Mazza, A. and Al-Nahhas, A. and Rubello, D.
Nuclear Medicine Communications. 2012; 33(2): 179-184
[Pubmed]  [Google Scholar]
34 SPECT and PET Imaging of Meningiomas
Varvara Valotassiou,Anastasia Leondi,George Angelidis,Dimitrios Psimadas,Panagiotis Georgoulias
The Scientific World Journal. 2012; 2012: 1
[Pubmed]  [Google Scholar] [DOI]
35 Mediastinal neuroendocrine tumor (atypical carcinoid probably of thymic origin) imitating teratoma - Case report [Guz śródpiersia o charakterze neuroendokrynnym (atypowy carcinoid prawdopodobnie z grasicy) przypominaja̧cy potworniaka - Opis przypadku]
Zielińska-Krawczyk, M. and Domagała-Kulawik, J. and Chazan, R.
Polski Merkuriusz Lekarski. 2011; 31(185): 280-283
[Pubmed]  [Google Scholar]
36 Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate-Specific Membrane Antigen
Sangeeta Ray Banerjee,Mrudula Pullambhatla,Youngjoo Byun,Sridhar Nimmagadda,Catherine A. Foss,Gilbert Green,James J. Fox,Shawn E. Lupold,Ronnie C. Mease,Martin G. Pomper
Angewandte Chemie International Edition. 2011; 50(39): 9167
[Pubmed]  [Google Scholar] [DOI]
37 Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate-Specific Membrane Antigen
Sangeeta Ray Banerjee,Mrudula Pullambhatla,Youngjoo Byun,Sridhar Nimmagadda,Catherine A. Foss,Gilbert Green,James J. Fox,Shawn E. Lupold,Ronnie C. Mease,Martin G. Pomper
Angewandte Chemie. 2011; 123(39): 9333
[Pubmed]  [Google Scholar] [DOI]
38 Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen
Banerjee, S.R., Pullambhatla, M., Byun, Y., Nimmagadda, S., Foss, C.A., Green, G., Fox, J.J., (...), Pomper, M.G.
Angewandte Chemie - International Edition. 2011; 50(39): 9167-9170
[Pubmed]  [Google Scholar]
39 From pure research imaging tool to PET-guided personalized medicine in oncology: A true revolution in modern medicine
S Basu
Indian Journal of Cancer. 2010; 47(2): 98
[Pubmed]  [Google Scholar] [DOI]
40 68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer
Banerjee, S.R., Pullambhatla, M., Byun, Y., Nimmagadda, S., Green, G., Fox, J.J., Horti, A., (...), Pomper, M.G.
Journal of Medicinal Chemistry. 2010; 53(14): 5333-5341
[Pubmed]  [Google Scholar]
41 From pure research imaging tool to PET-guided personalized medicine in oncology: A true revolution in modern medicine
Basu, S.
Indian Journal of Cancer. 2010; 47(2): 98-99
[Pubmed]  [Google Scholar]

 

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow